MétaCan
Menu
Back to cohort
Record W4324117130 · doi:10.1016/j.gimo.2023.100445

P409: Clinical utility of genomic sequencing for hereditary cancer syndromes: An observational chart review

2023· article· en· W4324117130 on OpenAlex
Salma Shickh, Chloe Mighton, Marc Clausen, Rita Kodida, Jordan Sam, Daena Hirjikaka, Emma Reble, Tracy Graham, Seema Panchal, Andrea Eisen, Christine Elser, Kasmintan A. Schrader, Nancy N. Baxter, Andreas Laupacis, Jordan Lerner‐Ellis, Raymond H. Kim, Yvonne Bombard

Why this work is in the frame

A frame that forgets how it found something cannot be audited. These are the routes that admitted this work.

affAt least one author lists a Canadian institution in the pinned OpenAlex snapshot.

Bibliographic record

VenueGenetics in Medicine Open · 2023
Typearticle
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicGenomics and Rare Diseases
Canadian institutionsCentre for Global Health ResearchSinai Health SystemUniversity Health NetworkHealth Sciences CentreSunnybrook Health Science Centre
Fundersnot available
KeywordsObservational studyGenomic sequencingComputational biologyCancerMedicineBiologyGeneticsBioinformaticsInternal medicineGenomeGene

Abstract

fetched live from OpenAlex

management approaches for hundreds of additional genetic disorders are available.Efforts such as the NIH-funded BabySeq Project explore the implications of genomic sequencing in healthy infants with the aim of designing strategies for implementation.Methods: We designed an online survey for rare disease experts (n = 389), investigating which additional treatable genetic conditions (currently not included on the RUSP) they recommend for screening in newborns using genomic sequencing.A list of 649 genes associated with treatable genetic conditions in 13 clinical areas was designed.Participants were invited to assess all proposed genes or to select the clinical area with which they were most familiar.We analyzed concordance among experts regarding screening specific genes in newborns.We also assessed responses to a series of descriptive questions about participant attitudes regarding universal genomic sequencing to screen newborns for treatable genetic disorders as well as the inclusion of disorders that are untreatable, lack confirmatory orthogonal tests, are of low penetrance, or are adult-onset.Results: A total of 238 (61.2%) experts, including directors of genetics and genomics programs accredited by the Accreditation Council for Graduate Medical Education (n = 64), physicians specializing in the care of rare disease patients (n = 165), and senior scientists within pharmaceutical companies specializing in rare disease therapeutics (n = 9) participated.Experts agreed with 85% concordance that 25 genes associated with disorders not currently included in universal NBS programs should be evaluated in presymptomatic infants (OTC, G6PC, SLC37A4, CYP11B1, ARSB, F8, F9, SLC2A1, CYP17A1, RB1, IDS, GUSB, DMD, GLUD1, CYP11A1, GALNS, CPS1, PLPBP, ALDH7A1, SLC26A3, SLC25A15, SMPD1, GATM, SLC7A7, NAGS).Orthogonal tests are available for confirmation of genetic disorders caused by 24 out of these 25 genes (96%).Clinical areas of interest included Metabolism, Neurology, Endocrinology and Hemato-Oncology.A total of 42 genes had 80% concordance and 432 genes had 50% concordance.Overall, 161 of 183 (87.9%) experts agreed or somewhat agreed that genomic sequencing should be used to expand the number of conditions included in NBS.Conclusion: While several of these genes are associated with clinical domains that are currently included in NBS, there are multiple candidates that represent new frontiers for NBS, such as hereditary cancer predisposition syndromes.This study highlights that experts endorse the expansion of NBS programs to include additional treatable monogenic disorders, including 25 high-priority conditions which could be efficiently screened using genomic sequencing.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.500
Threshold uncertainty score0.458

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0010.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0010.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.357
GPT teacher head0.488
Teacher spread0.131 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it